Casodex (BICALUTAMIDE) is an oral non-steroidal anti-androgen for prostate cancer. It is the world's leading anti-androgen and is available in all major European markets, the USA and Japan. Casodex was first launched in 1995 as a combination treatment (with surgical or medical castration) for advanced prostate cancer and subsequently launched as monotherapy for the treatment of earlier stages of the disease. Casodex has received approval as a monotherapy treatment in over 60 markets to date.
There are only few online pharmacies that provide customers with all the necessary information and services and that are allowed to sell Casodex online.
This price list shows offers from providers:
Additional offers with this product:
|
